These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38945353)

  • 1. Alteration of N6-methyladenosine modification profiles in the neutrophilic RNAs following ischemic stroke.
    Fan J; Zhong L; Yan F; Li X; Li L; Zhao H; Han Z; Wang R; Tao Z; Zheng Y; Ma Q; Luo Y
    Neuroscience; 2024 Aug; 553():56-73. PubMed ID: 38945353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptome-wide map of N6-methyladenosine (m6A) profiling in coronary artery disease (CAD) with clopidogrel resistance.
    Yu R; Yu Q; Li Z; Li J; Yang J; Hu Y; Zheng N; Li X; Song Y; Li J; Chen X; Du W; Su J
    Clin Epigenetics; 2023 Dec; 15(1):194. PubMed ID: 38098098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of N6-methyladenosine modification in pathogenesis of ischemic stroke.
    Chang H; Yang J; Wang Q; Zhao J; Zhu R
    Expert Rev Mol Diagn; 2022 Mar; 22(3):295-303. PubMed ID: 35236212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. m6A Regulators in Human Adipose Tissue - Depot-Specificity and Correlation With Obesity.
    Rønningen T; Dahl MB; Valderhaug TG; Cayir A; Keller M; Tönjes A; Blüher M; Böttcher Y
    Front Endocrinol (Lausanne); 2021; 12():778875. PubMed ID: 34950106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epitranscriptomic profiling of N6-methyladenosine-related RNA methylation in rat cerebral cortex following traumatic brain injury.
    Yu J; Zhang Y; Ma H; Zeng R; Liu R; Wang P; Jin X; Zhao Y
    Mol Brain; 2020 Jan; 13(1):11. PubMed ID: 31992337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Function and prognostic value of N6-methyladenosine-modified RNAs in lung adenocarcinoma.
    Liu J; Zheng Z; Zhong J
    J Gene Med; 2023 Jan; 25(1):e3454. PubMed ID: 36282144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential role of RNA N6-methyladenosine in primary Sjögren's syndrome.
    Xiao Q; Wu X; Deng C; Zhao L; Peng L; Zhou J; Zhang W; Zhao Y; Fei Y
    Front Med (Lausanne); 2022; 9():959388. PubMed ID: 36465909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential role of N6-methyladenosine modification of LncRNAs in contributing to the pathogenesis of chronic glomerulonephritis.
    Liu T; Zhuang XX; Qin XJ; Wei LB; Gao JR
    Inflamm Res; 2023 Mar; 72(3):623-638. PubMed ID: 36700958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FTO-Dependent N
    Mathiyalagan P; Adamiak M; Mayourian J; Sassi Y; Liang Y; Agarwal N; Jha D; Zhang S; Kohlbrenner E; Chepurko E; Chen J; Trivieri MG; Singh R; Bouchareb R; Fish K; Ishikawa K; Lebeche D; Hajjar RJ; Sahoo S
    Circulation; 2019 Jan; 139(4):518-532. PubMed ID: 29997116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N6-methyladenosine methylation analysis of long noncoding RNAs and mRNAs in 5-FU-resistant colon cancer cells.
    Lai J; Zhou Z; Hu K; Yu H; Su X; Niu X; Li H; Mao S
    Epigenetics; 2024 Dec; 19(1):2298058. PubMed ID: 38145548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N6-Methyladenosine Methylation Analysis of Long Noncoding RNAs and mRNAs in IPEC-J2 Cells Treated With
    Yang J; Yang Q; Zhang J; Gao X; Luo R; Xie K; Wang W; Li J; Huang X; Yan Z; Wang P; Gun S
    Front Immunol; 2021; 12():769204. PubMed ID: 34880865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA m6A modification, signals for degradation or stabilisation?
    Wei G
    Biochem Soc Trans; 2024 Apr; 52(2):707-717. PubMed ID: 38629637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demethylase FTO-Mediated m6A Modification of lncRNA MEG3 Activates Neuronal Pyroptosis via NLRP3 Signaling in Cerebral Ischemic Stroke.
    Yan H; Huang W; Rao J; Yan D; Yuan J
    Mol Neurobiol; 2024 Feb; 61(2):1023-1043. PubMed ID: 37676392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FTO-mediated regulation of m6A methylation is closely related to apoptosis induced by repeated UV irradiation.
    Lin Y; Sun Y; Hou W; Chen X; Zhou F; Xu Q; Zheng Y
    J Dermatol Sci; 2024 Jun; 114(3):124-132. PubMed ID: 38749796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tumor-suppressive effects of alpha-ketoglutarate-dependent dioxygenase FTO via N6-methyladenosine RNA methylation on bladder cancer patients.
    Yi W; Yu Y; Li Y; Yang J; Gao S; Xu L
    Bioengineered; 2021 Dec; 12(1):5323-5333. PubMed ID: 34499008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene Alterations of N6-Methyladenosine (m
    Zhang Q; Cai Y; Kurbatov V; Khan SA; Lu L; Zhang Y; Johnson CH
    Biomed Res Int; 2020; 2020():8826456. PubMed ID: 33415160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ibuprofen promotes p75 neurotrophin receptor expression through modifying promoter methylation and N6-methyladenosine-RNA-methylation in human gastric cancer cells.
    Jin H; Wu Z; Tan B; Liu Z; Zu Z; Wu X; Bi Y; Hu X
    Bioengineered; 2022 Jun; 13(6):14595-14604. PubMed ID: 35758042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N6-methyladenosine demethylase FTO regulates synaptic and cognitive impairment by destabilizing PTEN mRNA in hypoxic-ischemic neonatal rats.
    Deng J; Liao Y; Chen J; Chen A; Wu S; Huang Y; Qian H; Gao F; Wu G; Chen Y; Chen X; Zheng X
    Cell Death Dis; 2023 Dec; 14(12):820. PubMed ID: 38092760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synchronous profiling of mRNA N6-methyladenosine modifications and mRNA expression in high-grade serous ovarian cancer: a pilot study.
    Yang L; Liu J; Jin Y; Xing J; Zhang J; Chen X; Yu A
    Sci Rep; 2024 May; 14(1):10427. PubMed ID: 38714753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive Analysis of Blood-Based m6A Methylation in Human Ischemic Stroke.
    Zhu L; Liu S; Liao F; Yang J; Liang T; Yang Y; Huang X; Gu L; Su L
    Mol Neurobiol; 2023 Feb; 60(2):431-446. PubMed ID: 36279101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.